DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Spencer T, Biederman J, Heiligenstein J. et al.
An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder.
J Child Adolesc Psychopharmacol 2001;
11: 251-265
We do not assume any responsibility for the contents of the web pages of other providers.